Cosmos Holdings Inc. COSM
We take great care to ensure that the data presented and summarized in this overview for Cosmos Holdings Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in COSM
Top Purchases
Top Sells
About COSM
Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company. It offers proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care, baby products, medical devices, and other products through its distribution channels and an ecommerce market place. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. The company was formerly known as Prime Estates and Developments, Inc. and changed its name to Cosmos Holdings Inc. in November 2013. Cosmos Holdings Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Insider Transactions at COSM
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2024
|
Grigorios Siokas Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
257,334
+6.38%
|
$0
$0.58 P/Share
|
|
Dec 20
2024
|
Georgios Terzis Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
85,778
+10.55%
|
$0
$0.58 P/Share
|
|
Feb 16
2024
|
Grigorios Siokas Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
60,000
+4.12%
|
$0
$0.83 P/Share
|
|
Dec 22
2023
|
Anastasios Aslidis |
SELL
Sale (or disposition) back to the issuer
|
Direct |
200
-0.99%
|
$200
$1.46 P/Share
|
|
Oct 24
2023
|
Georgios Terzis Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,485
+25.24%
|
$51,485
$1.01 P/Share
|
|
Oct 12
2023
|
Grigorios Siokas Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
6,712
+0.5%
|
$154,376
$23.66 P/Share
|
|
Jul 20
2023
|
Grigorios Siokas Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
181,451
+12.02%
|
$362,902
$2.48 P/Share
|
|
Jun 06
2023
|
Grigorios Siokas Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,474
+0.39%
|
$102,902
$23.92 P/Share
|
|
Apr 27
2023
|
Grigorios Siokas Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,474
+0.39%
|
$107,376
$24.64 P/Share
|
|
Apr 21
2023
|
Grigorios Siokas Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,474
+0.39%
|
$107,376
$24.49 P/Share
|
|
Apr 07
2023
|
Grigorios Siokas Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,238
+0.2%
|
$53,712
$24.37 P/Share
|
|
Apr 03
2023
|
Anastasios Aslidis |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+49.75%
|
-
|
|
Apr 03
2023
|
Manfred Ziegler |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Apr 03
2023
|
Nikolaos Bardakis Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
|
Apr 03
2023
|
John James Hoidas |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Apr 03
2023
|
Georgios Terzis Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+49.76%
|
-
|
|
Apr 03
2023
|
Pavlos Ignatiades Chief Communications Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Dec 19
2022
|
Grigorios Siokas Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
260,870
+18.75%
|
$2,869,570
$11.5 P/Share
|
|
Dec 02
2022
|
Grigorios Siokas Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
1,131,098
+4.94%
|
$0
$0.62 P/Share
|
|
Nov 30
2022
|
Grigorios Siokas Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
481,079
+2.28%
|
$0
$0.62 P/Share
|
Last 12 Months Summary
| Open market or private purchase | 403K shares |
|---|